Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosemary A Hannon

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer Treatment Reviews|May 9, 2006
Bone markers and current laboratory assaysRosemary A Hannon, Richard Eastell
The Proceedings of the Nutrition Society|April 17, 2008
Biomarkers of bone health and osteoporosis riskRichard Eastell, Rosemary A Hannon
The Journal of the British Menopause Society|June 14, 2003
Biochemical markers of bone turnover and fracture predictionRosemary A Hannon, Richard Eastell
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Effect of stopping risedronate after long-term treatment on bone turnoverRichard Eastell, Rosemary A Hannon, Dietrich Wenderoth, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2007
Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: review of statistical analysisRichard Eastell, Rosemary A Hannon, Patrick Garnero, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2006
Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230)Richard Eastell, Rosemary A Hannon, Jack Cuzick, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 12, 2003
Absence of marked seasonal change in bone turnover: a longitudinal and multicenter cross-sectional studyAubrey Blumsohn, Kim E Naylor, Wolfram Timm, et al.
Bone|January 31, 2004
Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorptionRosemary A Hannon, Jackie A Clowes, Alison C Eagleton, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 25, 2009
Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trialRosemary A Hannon, Glen Clack, Martin Rimmer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 6, 2007
Risk factors for vertebral and nonvertebral fracture over 10 years: a population-based study in womenJudith Finigan, Diana M Greenfield, Aubrey Blumsohn, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Treatment Reviews|May 9, 2006
Bone markers and current laboratory assaysRosemary A Hannon, Richard Eastell
The Proceedings of the Nutrition Society|April 17, 2008
Biomarkers of bone health and osteoporosis riskRichard Eastell, Rosemary A Hannon
The Journal of the British Menopause Society|June 14, 2003
Biochemical markers of bone turnover and fracture predictionRosemary A Hannon, Richard Eastell
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Effect of stopping risedronate after long-term treatment on bone turnoverRichard Eastell, Rosemary A Hannon, Dietrich Wenderoth, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2007
Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: review of statistical analysisRichard Eastell, Rosemary A Hannon, Patrick Garnero, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2006
Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230)Richard Eastell, Rosemary A Hannon, Jack Cuzick, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 12, 2003
Absence of marked seasonal change in bone turnover: a longitudinal and multicenter cross-sectional studyAubrey Blumsohn, Kim E Naylor, Wolfram Timm, et al.
Bone|January 31, 2004
Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorptionRosemary A Hannon, Jackie A Clowes, Alison C Eagleton, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 25, 2009
Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trialRosemary A Hannon, Glen Clack, Martin Rimmer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 6, 2007
Risk factors for vertebral and nonvertebral fracture over 10 years: a population-based study in womenJudith Finigan, Diana M Greenfield, Aubrey Blumsohn, et al.
Pageof 2